Nephroangiosclerosis and Its Pharmacological Approach

Author(s): Rosario Cianci, Biagio Barbano, Paola Martina, Antonietta Gigante, Lelio Polidori, Silvia Lai, Giada Ascoli, Irene De Francesco, Domenico Di Donato, Giorgio Fuiano, Alessandro Zuccala.

Journal Name: Current Vascular Pharmacology

Volume 9 , Issue 2 , 2011

Become EABM
Become Reviewer


Nephroangiosclerosis (NAS) is a major cause of progressive renal insufficiency. Hypertension is very important in the causation of NAS but other factors such as race, age, metabolic variables, and genetics play a pathogenic and prognostic role. A multifactorial treatment strategy, including antihypertensive, lipid-lowering and anti-platelet agents, could improve cardiovascular and renal outcomes in patients with vascular nephropathy.

Keywords: Nephroangiosclerosis, vascular nephropathy, hypertension, renal failure, statins

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [238 - 243]
Pages: 6
DOI: 10.2174/157016111794519309
Price: $65

Article Metrics

PDF: 2